Literature DB >> 19172368

Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

E Pardina1, M D López-Tejero, R Llamas, R Catalán, R Galard, H Allende, V Vargas, A Lecube, J M Fort, J A Baena-Fustegueras, J Peinado-Onsurbe.   

Abstract

BACKGROUND: Although bariatric surgery is the most common procedure used to induce weight loss in morbidly obese patients, its effect on plasma satiety factors (leptin, ghrelin, and apolipoprotein (apo)-AIV) is controversial. The aim of this work was to analyze these parameters before and at different times after surgery.
METHODS: Plasma was obtained from 34 patients before undergoing Roux-en-Y gastric bypass and during weight loss in the 12 months following surgery.
RESULTS: Morbidly obese patients had significantly higher values (147%) of leptin than normal-weight (NW) persons, while their ghrelin levels were 46% less than NW. Apo-AIV levels had approximately the same value in both groups (obese and NW). During weight loss, leptin decreased by 75% and ghrelin increased by 78%. Both parameters reached values less than or near NW, respectively, at 1 year after surgery. During the first month after surgery, apo-AIV plasma levels decreased (47%) but later increased and finally returned to preoperative values. Apo-AIV levels were correlated negatively with leptin and positively with ghrelin. High-density lipoprotein (HDL) levels were positively correlated with those of ghrelin and apo-AIV.
CONCLUSIONS: During weight loss, plasma leptin and ghrelin could be good markers of total fat decrease. Ghrelin could also indicate gastric mucous improvement, whereas apo-AIV could indicate the recovery of intestinal function. Changes produced in the HDL levels of morbidly obese patients during weight loss suggest a decreased risk of coronary disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172368     DOI: 10.1007/s11695-008-9793-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  51 in total

1.  The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus.

Authors:  Gema Frühbeck; Alberto Diez-Caballero; M Jesús Gil; Inés Montero; Javier Gómez-Ambrosi; Javier Salvador; Javier A Cienfuegos
Journal:  Obes Surg       Date:  2004-05       Impact factor: 4.129

2.  The early effects of weight loss surgery on regional adiposity.

Authors:  Madeleine L Phillips; Mark C Lewis; Veronica Chew; Lilian Kow; John P Slavotinek; Lynne Daniels; Robin Valentine; Jim Toouli; Campbell H Thompson
Journal:  Obes Surg       Date:  2005 Nov-Dec       Impact factor: 4.129

Review 3.  The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review.

Authors:  M D Klok; S Jakobsdottir; M L Drent
Journal:  Obes Rev       Date:  2007-01       Impact factor: 9.213

Review 4.  Leptin regulation of neuroendocrine systems.

Authors:  R S Ahima; C B Saper; J S Flier; J K Elmquist
Journal:  Front Neuroendocrinol       Date:  2000-07       Impact factor: 8.606

5.  Serum lipids after gastric bypass surgery for morbid obesity.

Authors:  R E Brolin; H A Kenler; A C Wilson; P T Kuo; R P Cody
Journal:  Int J Obes       Date:  1990-11

Review 6.  Overview of operations for morbid obesity.

Authors:  M Deitel
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

7.  Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase.

Authors:  Nicholas J Beaumont; Vernon O Skinner; Tricia M-M Tan; Bala S Ramesh; Dominic J Byrne; Gavin S MacColl; Jeff N Keen; Pierre M Bouloux; Dimitri P Mikhailidis; K Richard Bruckdorfer; Mark P Vanderpump; Kaila S Srai
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

8.  Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans.

Authors:  Camilla Holdstock; Britt Edén Engström; Margareta Ohrvall; Lars Lind; Magnus Sundbom; F Anders Karlsson
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

9.  The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Authors:  Francesco Rubino; Michel Gagner; Paolo Gentileschi; Subhash Kini; Shoji Fukuyama; John Feng; Ed Diamond
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  Leptin and soluble leptin receptor levels in obese and weight-losing individuals.

Authors:  Francois M H van Dielen; Cornelis van 't Veer; Wim A Buurman; Jan Willem M Greve
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

View more
  14 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

Review 2.  Morbid obesity and sleeve gastrectomy: how does it work?

Authors:  Joanna Papailiou; Konstantinos Albanopoulos; Konstantinos G Toutouzas; Christos Tsigris; Nikolaos Nikiteas; George Zografos
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

3.  Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up.

Authors:  Noelia Pérez-Romero; Assumpta Serra; Maria Luisa Granada; Miquel Rull; Antonio Alastrué; Maruja Navarro-Díaz; Ramón Romero; Jaime Fernández-Llamazares
Journal:  Obes Surg       Date:  2009-12-17       Impact factor: 4.129

Review 4.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

6.  Glucagon-Like Peptides 1 and 2 Are Involved in Satiety Modulation After Modified Biliopancreatic Diversion: Results of a Pilot Study.

Authors:  Everton Cazzo; José Carlos Pareja; Elinton Adami Chaim; Cláudio Saddy Rodrigues Coy; Daniéla Oliveira Magro
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

7.  Circulating Apolipoprotein A-IV presurgical levels are associated with improvement in insulin sensitivity after Roux-en-Y gastric bypass surgery.

Authors:  Raghavendra Rao; Alexander Roche; Gerardo Febres; Marc Bessler; Patrick Tso; Judith Korner
Journal:  Surg Obes Relat Dis       Date:  2016-10-26       Impact factor: 4.734

8.  Biliopancreatic Diversion Decreases Postprandial Apolipoprotein A-IV Levels in Mildly Obese Individuals with Type 2 Diabetes Mellitus: a Prospective Study.

Authors:  Everton Cazzo; José Carlos Pareja; Bruno Geloneze; Elinton Adami Chaim; Maria Rita Lazzarini Barreto; Daniéla Oliveira Magro
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

9.  Evolution of lipid profiles after bariatric surgery.

Authors:  Ignacio Garcia-Marirrodriga; Cesar Amaya-Romero; Gabriel Patiño Ruiz-Diaz; Sandra Férnandez; Carlos Ballesta-López; Jose M Pou; June H Romeo; Gemma Vilahur; Gemma Vilhur; Lina Badimon; Juan Ybarra
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

Review 10.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.